Cyrus M. has extensive experience in the biopharmaceutical and investment sectors, currently serving on the Board of Directors for Sanguine Biosciences and as Chairman and Managing Partner at Bioselective Capital Investments. Since April 2021, Cyrus has held advisory roles at Advent International and as an Investment Advisor for Bridgewest Ventures NZ. Additionally, Cyrus contributes as a Director and Board Member for BioOra, aiming to enhance cancer therapy innovation in New Zealand. Recent executive roles include Chief Executive Officer at both LumaCina, a supplier of sterile injectable pharmaceutical products, and NovaCina, a contract development and manufacturing organization based in Perth, Australia. Cyrus previously held leadership positions at BioDuro-Sundia and Formex, LLC. Cyrus holds a Bachelor of Science in Biology from UC Irvine.
Previous companies
Org chart
Teams
This person is not in any teams
Offices
This person is not in any offices
Sanguine
4 followers
Sanguine Biosciences is a pioneer of in-home specimen collection and a leader in direct-to-patient recruitment and digital health innovation. They partner with researchers on their study designs and support cross-sectional and longitudinal analyses with complex patient inclusion/exclusion sample collection criteria.
